Adrenal disease

Presentation and clinical patterns of bilateral adrenal lesions: a retrospective cohort study

J Clin Endocrinol MetabPublished Retrospective cohort study

Authors' conclusion

Most bilateral adrenal masses are benign and concordant; however, discordant or asynchronous disease identifies a higher-risk subgroup enriched for malignancy. Early contralateral lesion development and larger tumor size are key risk factors.

Study context

Population
Adults with bilateral adrenal masses, tertiary referral center, 2010–2025; median age 59.6 years, 51% women
Participants
1,035 adults
Exposure
Asynchronous vs synchronous presentation; concordant vs discordant etiology
Outcome
Etiology, concordance, synchronicity, interval to contralateral lesion, and factors associated with discordance and malignant or pheochromocytoma contralateral lesions
Methodological detailssingle-centre, tertiary referral center
  • Single-centre
  • Tertiary referral center

Main finding

As reported in the abstract

Concordant etiologies
85%
Discordant etiologies
15%
Concordant cases: bilateral benign cortical lesions
76%
Discordant cases: benign
35%
Discordant cases: malignant
31%
Discordant cases: indeterminate
34%
Synchronous presentation
84%
Asynchronous presentation
16%
Median interval to contralateral lesion, months (IQR 15-87)
45

Observational data: associations, not effects.

Further findings

Discordance

P = 0.001

Malignant lesions (bilateral malignant; discordant malignant) · value = bilateral malignant

overall P < .001

Discordant malignant

OutcomeaOR (95% CI)
Malignant or pheochromocytoma etiology among asynchronous casesInterval to contralateral lesion <2 yearsvs ≥5 years2.63 (1.01–6.85)

Malignant or pheochromocytoma etiology among asynchronous cases

aOR per mm (95% CI)
Larger tumor size1.06 (1.02–1.09)

Original publication

Presentation and clinical patterns of bilateral adrenal lesions: a retrospective cohort study. J Clin Endocrinol Metab. Published 12 May 2026. doi:10.1210/clinem/dgag199

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.